This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates.

Roger Scarlett-Smith named President of GlaxoSmithKline Consumer Healthcare North America

FOR IMMEDIATE RELEASE

Pittsburgh, May 27, 2008 – GlaxoSmithKline [GSK] Consumer Healthcare named Roger Scarlett-Smith as President, Consumer Healthcare, North America effective immediately.  Scarlett-Smith succeeds George Quesnelle, who will now hold the position of President, Global Switch and Strategic Growth Projects. 

Scarlett-Smith will head operations, including sales and marketing, of the Consumer Healthcare North American business, headquartered in Pittsburgh, employing more than 500 associates locally and more than 1400 throughout North America.  He will relocate from London to Pittsburgh.  

Scarlett-Smith previously led the United Kingdom GSK Consumer Healthcare business and home of such well-known brands as Macleans, Aquafresh, Sensodyne, Lucozade, and Panadol.  He also held general management roles in Australia and New Zealand, and global marketing roles with the Analgesics, Respiratory and Dermatology businesses within GSK Consumer Healthcare.  Between 1993 – 1996, Scarlett-Smith worked in the North American business, based in Pittsburgh, as Vice President, Marketing for Oral Healthcare and Cough & Cold.

In his new role, George Quesnelle will lead the development of major global growth projects, including Rx to over-the-counter switches and the creation of a long-term switch pipeline that will deliver future growth for the business.  As President, North America, Quesnelle successfully led the North American business to a period of rapid growth, including such achievements as the world-class switch and launch of alli and the successful acquisition and integration of the Breathe Right and FiberChoice brands.  Quesnelle will continue to be based in Pittsburgh.

GlaxoSmithKline Consumer Healthcare is one of the world’s largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette^® and NicoDerm^®CQ^®, and Commit^®, as well as many medicine cabinet staples – alli^®, Aquafresh^®, Sensodyne^®, and TUMS^®– which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.

# # #

CONTACT:

Malesia Dunn

412-200-3544